Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.3, indicating a recent update to the page's version history. The change is metadata-level and does not modify the study details or user-facing content on the page.
    Difference
    0.1%
    Check dated 2026-06-30T03:03:06.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page updates include a recruitment status line indicating recruitment is closed, the addition of user-help sections (How to Read a Study Record, Common Questions, How to Join a Study), and a standardized Intervention/Treatment heading; the revision tag is updated to v3.6.0 and the older v3.5.5 tag is removed.
    Difference
    0.5%
    Check dated 2026-06-14T17:45:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    An updated revision tag indicates a minor platform update from v3.5.4 to v3.5.5; no study data or page content related to the trial is changed.
    Difference
    0.1%
    Check dated 2026-06-07T14:46:45.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Updated the page revision from v3.5.3 to v3.5.4, indicating a minor update to the site's versioning or content-management state. No study details or user-facing content were changed.
    Difference
    0.1%
    Check dated 2026-05-17T05:36:50.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-25T17:52:43.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:16:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.